Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
Jan Lejman, Kinga Panuciak, Emilia Nowicka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 22

Showing 22 citing articles:

Non-viral delivery of nucleic acid for treatment of rare diseases of the muscle
Divya Rao, Munia Ganguli
Journal of Biosciences (2024) Vol. 49, Iss. 1
Closed Access | Times Cited: 6
An Updated Review of the SMA Clinical Trial Landscape in the United States: Findings from Analysis of Recruitment Targets on ClinicalTrials.gov and a Survey of SMA Clinical Trial Sites on Factors Affecting Site Capacity and Readiness
Fatou Sarr, Ilse Peterson, Jacqueline Glascock, et al.
Research Square (Research Square) (2025)
Closed Access
Integrative transcriptome profiling for identifying ALS potential treatment using the drug repurposing approach
Navid Kashani, Amir Sabbaghian, Fatemeh EmamiPari, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Muscle Matters: Transforming Amyotrophic Lateral Sclerosis Diagnostics with Next-Gen Biosensors and Smart Detection
Saumitra Singh, Sameer Khan, Shahbaz Khan, et al.
ACS Chemical Neuroscience (2025)
Closed Access
Gene therapy for aromatic L‐amino acid decarboxylase deficiency: Requirements for safe application and knowledge‐generating follow‐up
Agathe Roubertie, Thomas Opladen, Heiko Brennenstuhl, et al.
Journal of Inherited Metabolic Disease (2023) Vol. 47, Iss. 3, pp. 463-475
Open Access | Times Cited: 10
Long term peripheral AAV9-SMN gene therapy promotes survival in a mouse model of spinal muscular atrophy
Aoife Reilly, Rebecca Yaworski, Ariane Beauvais, et al.
Human Molecular Genetics (2023) Vol. 33, Iss. 6, pp. 510-519
Closed Access | Times Cited: 10
Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases
Jiazi Ma, Jian‐Wei Liu, Shangya Chen, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 8
Open Access | Times Cited: 3
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Eva Bagyinszky, John Hulme, Seong Soo A. An
Cells (2023) Vol. 12, Iss. 15, pp. 1948-1948
Open Access | Times Cited: 7
Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
Roberta Romanò, Cecilia Bucci
Neural Regeneration Research (2023) Vol. 19, Iss. 5, pp. 1027-1035
Open Access | Times Cited: 7
The various forms of hereditary motor neuron disorders and their historical descriptions
Stéphane Mathis, Diane Beauvais, Fanny Duval, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3978-3990
Closed Access | Times Cited: 2
Gene Therapy in Neurological Diseases
Mehmet Ufuk Aluçlu
Gene Therapy (2024), pp. 93-105
Closed Access | Times Cited: 1
Experiences and the psychosocial situation of parental caregivers of children with spinal muscular atrophy against the background of new treatment options: a qualitative interview study
Maja Brandt, Joenna Driemeyer, Jessika Johannsen, et al.
BMC Psychology (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Clinical aspects of motor neurone disease
Richard W. Orrell, R J Guiloff
Medicine (2023) Vol. 51, Iss. 9, pp. 658-662
Open Access | Times Cited: 3
Functionalized magnetic nanoparticles for cancer therapy
Mahdi Sabzini, Ashkan Moradi, Hamidreza Sahrayi, et al.
Elsevier eBooks (2024), pp. 435-457
Closed Access
The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment
Le Yi Wang, Lei Zhang, Xin Yue Bai, et al.
Neurochemical Research (2024) Vol. 49, Iss. 10, pp. 2653-2667
Closed Access
Gene Therapy in Hereditary Diseases
İlyas Yücel, Mahir Binici
Gene Therapy (2024), pp. 129-152
Closed Access
Low intensity exercise training in patients with amyotrophic lateral sclerosis – factors influencing eligibility and compliance to the clinical trial
Jan Sznajder, Krzysztof Barć, Magdalena Kuźma‐Kozakiewicz
Neurological Research (2023) Vol. 45, Iss. 8, pp. 708-716
Closed Access | Times Cited: 1
Neurological Disorders and Challenges in Their Theranostics
Prabhat Kumar, Dóra Zelena, Akash Gautam
(2023), pp. 1-29
Closed Access | Times Cited: 1
Spinal muscular atrophy – the effectiveness of treatment and new therapeutic possibilities for selected groups of patients in Poland
Katarzyna Kozon, Małgorzata Krzyżanowska, Jakub Olszewski, et al.
Prospects in Pharmaceutical Sciences (2023) Vol. 21, Iss. 2, pp. 68-72
Open Access
Analysis on the effect of genes on amyotrophic lateral sclerosis
Jiayi Zang
Theoretical and Natural Science (2023) Vol. 6, Iss. 1, pp. 229-233
Closed Access
Preferences of Patients with Amyotrophic Lateral Sclerosis for Intrathecal Drug Delivery: Choosing between an Implanted Drug-Delivery Device and Therapeutic Lumbar Puncture
Jaein Seo, Sandeep Saurkar, Gabriela Fernandez, et al.
Patient (2023) Vol. 17, Iss. 2, pp. 161-177
Closed Access
A REVIEW ON OVERVIEW OF GENE AND RNA BASED THERAPIES
Tandel Muskan Vijaykumar, Prajapati Hardikkumar Bharatbhai, Anuradha Prajapati, et al.
EPRA International Journal of Research & Development (IJRD) (2023), pp. 297-302
Open Access
Page 1

Scroll to top